1Hovind P, Rossing P, Tarnow L, et al. Progression of diabetic nephropathy. Kidney Int. 2001: 59: 702-709.
2Ravid M, Brosh D, Ravid-Safran D, et al. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med. 1998; 158: 998-1004.
3Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria and the progression of renal disease: The Modification of Diet in Renal Disease Study.Ann Intern Med. 1995: 123: 754-762.
4Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med.2001; 161: 1207-1216.
5Hansson L, Zanchett A, Carruthers SG, et al. Effects of intensive blood pressure lowering a low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial. The HOT Study Group Lancet. 1998; 351: 1755-1762.
6Mailloux LU, Levey AS. Hypertension in chronic renal disease. Am J Kidney Dis. 1998 32 (s3): S120-S141.
7Ruggenenti P, Remuzzi G. Angiotensin--converting enzyme inhibitor therapy for non-diabetic progressive renal disease. Curr Opin Nephrol Hypertens. 1997; 6:489-495.
8Jafar TH, Schmid CH, Landa M, et al. Angiotansin-converting enzyme inhibitors and the progression of non-diabetic renal disease: A meta-analysis of patiant level data. Ann Intern Med. 2001: 135: 73-87.
9Lewis EJ, Hunsicker LG, Clarke WR, et al.Renoprotective effect of the angiotensinreceptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.N Engl J Med. 2001; 345: 851-860.
10Brenner BM,Copper ME,de Zeeuw D,et al.The RENAAL Study Investigators,Effects of losartan on renal and ardiovascular outcomes in patients with type 2 diabetes and nephropathy.N Engl Med.2001;345:861-869.
2WALLERSON DC, DEVEREUX R. REPRODUCIBILITY of echocardiography left ventricular measurements [ J ]. Hypertension, 1987,9 (2) :116.
3NUNEZ E, ARNETT DK, BENJAMIN EJ, et al. Comparison of the prognostic value of left ventricular hypertrophy in African - America men versus women [ J ]. Am J Cardiol, 2004, 94 ( 11 ) : 1383 - 1390.
4National Kidney Foundation. K/DOQ1 clinical practice guidelines for chronic kidney disease:evaluation, classification, and stratification[ J ]. Am J Kidney Dis, 2002,39 (2 Suppl 1 ) : S1 - 266.
5LORELL BH. Cardiac rennin anglotensin system:Role in development of pressure overload hypertrophy [ J ]. Can J Cardiol, 1995,11 (Suppl F) :2 -7.
6MATSUSAKS T. HYMES J, ICHIKAWA I. Angiotensin in Progression renal disease;Theory and Practice[J]. An Soc Nephrol,1996 (7) :2025.
